News
The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...
RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...
17h
Medindia on MSNFDA Approves ENFLONSIA to Shield Infants From RSVIn a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...
7h
YourErie on MSNFDA approves expanded use of Moderna’s RSV shot, but uncertainty remainsThe Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
Albertans who want to continue to protect themselves from the COVID-19 virus will have to pay out of pocket for it starting in the fall of 2025, the province announced on Friday.
The University of Washington’s Helen Chu, a leading voice in the COVID-19 pandemic, said she’s worried about where the panel ...
Dr. Dana Varble, Chief Veterinary Officer for the North American Veterinary Community, joins Lisa Dent to discuss signs that show if your dog needs more exercise. Than, Dr. Varble answers pet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results